Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56820bbb13a42311271e147869a36d30 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0058 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 |
filingDate |
2013-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98d0a4ecf4c405ba104183d777a900da http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_977ce5a65fe3a9cddb7029013a655995 |
publicationDate |
2014-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20140136804-A |
titleOfInvention |
Composition for treating pigmentary disorder through sFRP2 modulation |
abstract |
The present invention relates to a composition for the treatment or prevention of a pigment disease such as vitiligo or stain. The present invention also relates to a method for treating or preventing a pigment disease such as vitiligo, spots, and the like. The present invention uses an sFRP2 protein as an active ingredient for treating or preventing vitiligo, and uses a substance that inhibits the expression or activity of sFRP2 as an active ingredient for treating or preventing spots. |
priorityDate |
2013-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |